Onesource Specialty Pharma Board of Directors
Get the latest insights into the leadership at Onesource Specialty Pharma. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Neeraj Sharma | Managing Director |
| Mr. Arun Kumar Pillai | Non Exe.Non Ind.Director |
| Mr. Mahadevan Narayanamoni | Non Exe.Non Ind.Director |
| Mr. Bhushan Sudhir Bopardikar | Non Exe.Non Ind.Director |
| Mr. Bharat Dhirajlal Shah | Non Exe.Non Ind.Director |
| Mr. Gopakumar Gopalan Nair | Ind. Non-Executive Director |
| Ms. Rajashri Santosh Kumar Ojha | Ind. Non-Executive Director |
| Ms. Rashmi Harshadrai Barbhaiya | Ind. Non-Executive Director |
Onesource Specialty Pharma Share price
ONESOURCE
1880.1
12.10 (-0.64%)NSE
BSE
Last updated on 1 Sep, 2025 | 15:41 IST
BUYSELL
Today's High
1897.70
Today's Low
1863.00
52 Week Low
1209.95
52 Week High
2248.00
The current prices are delayed, login to your account for live prices
LoginOnesource Specialty Pharma FAQs
The board at Onesource Specialty Pharma consists of experienced professionals, including Mr. Neeraj Sharma , Mr. Arun Kumar Pillai , and others, overseeing the company’s strategic and corporate governance.
Directors at Onesource Specialty Pharma are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Neeraj Sharma is the current chairman at Onesource Specialty Pharma.
Executive directors at Onesource Specialty Pharma are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Onesource Specialty Pharma adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Onesource Specialty Pharma, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.